Substance Dependence Clinical Trial
Official title:
Distress Tolerance Treatment for Substance Users
Despite recent advances in substance abuse interventions, a large percentage of clients
entering residential treatment for substance use will drop out of treatment prematurely, and
of the remaining, many will relapse soon after treatment completion. Previous research
indicates that an individual's ability to withstand psychological distress is a key factor
necessary to maintain drug and alcohol abstinence and to remain in substance use treatment
without absconding. In previous work, Dr. Bornovalova developed a specific distress tolerance
treatment called Skills for Improving Distress Intolerance (SIDI). This intervention features
skills training in behavioral and acceptance strategies and intentional clinical exposure to
emotional distress. SIDI was developed and piloted with a sample of urban drug users seeking
treatment in a residential facility. Individuals receiving SIDI exhibited greater improvement
in distress tolerance than those in two comparison groups (receiving treatment-as-usual and
supportive counseling).
Current study. The investigators received NIDA funding to conduct a randomized clinical trial
with 325 clients entering a residential substance use treatment facility. Study participants
will be randomized into two treatment groups: (1) those receiving SIDI and (2) those
receiving Supportive Counseling (SC). Participants will receive 10 treatment sessions over a
period of 4 months. Then, the investigators will follow clients for one year to examine
treatment retention and abstinence.
Status | Recruiting |
Enrollment | 325 |
Est. completion date | September 1, 2019 |
Est. primary completion date | September 12, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion criteria: - 18-65 years of age - Not evidencing severe cognitive deficits - Ability to give informed consent Exclusion criteria: - <18 years of age or > 65 years of age - Not evidencing severe cognitive deficits (site designation of 'not competent to stand trial') - Unable to give informed consent |
Country | Name | City | State |
---|---|---|---|
United States | Agency for Community Treatment Services, Inc | Tarpon Springs | Florida |
Lead Sponsor | Collaborator |
---|---|
University of South Florida |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | successful/unsuccessful completion of residential addictions treatment | successful/unsuccessful completion of residential addictions treatment | Baseline, post-treatment (at 3 month mark in residential facility), successful discharge within 6 months from residential facility | |
Other | time in jail | measured by public records (# of days in jail by each timepoint) | 1, 3, 6 month follow-up in community | |
Other | psychiatric distress | psychiatric distress on brief symptom inventory | post-treatment at 3 month mark in residential facility, 1, 3, 6 month follow-up in community | |
Other | maladaptive personality | change in maladaptive personality on the Personality Inventory for DSM5 | post-treatment (at 3 month mark in residential facility), 1, 3, 6 month follow-up in community | |
Primary | abstinence at 1, 3, 6 & 12 month follow-up | Measured via biological verification and timeline follow-back | 1, 3, 6 month follow-up post-treatment | |
Secondary | distress tolerance | ability to tolerate psychological distress | 1, 3, 6 month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00887367 -
EtOH Interaction Study
|
Phase 1 | |
Completed |
NCT01036061 -
GSK618334 Repeat Dose Study
|
Phase 1 | |
Completed |
NCT01189799 -
Motivational Therapy for Substance Users With Depression
|
N/A | |
Completed |
NCT01381133 -
Adolescent Outpatient and Continuing Care Study
|
Phase 3 | |
Recruiting |
NCT04430257 -
Pre-exposure Prophylaxis (PrEP) for Health
|
N/A | |
Completed |
NCT01128140 -
Efficacy Trial of Warrior Check-Up
|
Phase 2 | |
Completed |
NCT03767907 -
Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial
|
N/A | |
Recruiting |
NCT05833399 -
Correlation of Genetic Variations With Clinical Response in Substance Use Disorder
|
||
Withdrawn |
NCT01515917 -
Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
|
N/A | |
Completed |
NCT00208143 -
Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia
|
Phase 4 | |
Withdrawn |
NCT03762798 -
Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone
|
N/A | |
Completed |
NCT03048552 -
Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3
|
N/A | |
Active, not recruiting |
NCT04768920 -
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
|
N/A | |
Recruiting |
NCT05410561 -
Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients
|
N/A | |
Recruiting |
NCT05679284 -
A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
|
||
Withdrawn |
NCT00908206 -
Effects of GSK598809 on Brain Activation in Abstinent Alcoholics
|
Phase 1 | |
Recruiting |
NCT05348317 -
Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders
|
N/A | |
Active, not recruiting |
NCT01621711 -
Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care
|
N/A | |
Active, not recruiting |
NCT00609089 -
Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction
|
Phase 1/Phase 2 | |
Completed |
NCT00288886 -
Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment
|
Phase 2 |